TCA
TMO icon

Transcend Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Transcend Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Buy
2,323
+111
+5% +$60.2K 0.09% 213
2025
Q4 		$1.28M Sell
2,212
-3,364
-60% -$1.9M 0.1% 192
2025
Q3 		$2.7M Sell
5,576
-155
-3% -$72.1K 0.19% 114
2025
Q2 		$2.32M Sell
5,731
-1,486
-21% -$621K 0.18% 129
2025
Q1 		$3.59M Sell
7,217
-157
-2% -$85K 0.26% 96
2024
Q4 		$3.84M Sell
7,374
-291
-4% -$160K 0.28% 90
2024
Q3 		$4.74M Sell
7,665
-166
-2% -$98.3K 0.32% 74
2024
Q2 		$4.33M Buy
7,831
+268
+4% +$154K 0.31% 70
2024
Q1 		$4.4M Sell
7,563
-23
-0.3% -$12.9K 0.35% 65
2023
Q4 		$4.03M Buy
7,586
+188
+3% +$91K 0.36% 63
2023
Q3 		$3.74M Buy
7,398
+830
+13% +$442K 0.37% 62
2023
Q2 		$3.43M Buy
6,568
+172
+3% +$92.8K 0.33% 71
2023
Q1 		$3.69M Sell
6,396
-456
-7% -$257K 0.38% 56
2022
Q4 		$3.77M Sell
6,852
-239
-3% -$127K 0.41% 52
2022
Q3 		$3.6M Buy
7,091
+131
+2% +$73.3K 0.4% 53
2022
Q2 		$3.78M Buy
6,960
+382
+6% +$210K 0.39% 54
2022
Q1 		$3.88M Buy
6,578
+16
+0.2% +$9.19K 0.35% 68
2021
Q4 		$4.38M Buy
6,562
+441
+7% +$275K 0.39% 62
2021
Q3 		$3.72M Buy
6,121
+50
+0.8% +$27.4K 0.33% 74
2021
Q2 		$3.07M Buy
6,071
+239
+4% +$113K 0.44% 61
2021
Q1 		$2.66M Buy
5,832
+6
+0.1% +$2.86K 0.32% 81
2020
Q4 		$2.71M Buy
5,826
+427
+8% +$200K 0.36% 76
2020
Q3 		$2.38M Buy
+5,399
New +$2.23M 0.43% 58
2020
Q2 		– Sell
-5,004
Closed -$1.42M – 194
2020
Q1 		$1.42M Sell
5,004
-48
-1% -$15.1K 0.43% 70
2019
Q4 		$1.64M Buy
+5,052
New +$1.53M 0.44% 72

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Transcend Capital Advisors's TMO Position: Q1 2026 in Review

Transcend Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 5% in Q1 2026, buying an estimated $60.2K and bringing the position to 2,323 shares worth $1.14M. The position accounts for 0.09% of the portfolio, ranked #213.

Transcend Capital Advisors first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $4.74M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Transcend Capital Advisors held 2,323 shares of Thermo Fisher Scientific worth $1.14M as of Q1 2026.
  • Transcend Capital Advisors bought 111 Thermo Fisher Scientific shares in Q1 2026, an estimated $60.2K.
  • Thermo Fisher Scientific made up 0.09% of Transcend Capital Advisors's portfolio in Q1 2026, its #213 holding.
  • Transcend Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
  • Transcend Capital Advisors's Thermo Fisher Scientific position peaked at $4.74M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.